Whitehawk Therapeutics, Inc.

WHWK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 15, 2026
4 Jun 15, 2026
4 Jun 15, 2026
4 Jun 15, 2026
4 Jun 15, 2026
8-K Jun 12, 2026 8-K
EFFECT Jun 9, 2026
CORRESP Jun 5, 2026
UPLOAD Jun 5, 2026
S-3 May 29, 2026 S-3
8-K May 21, 2026 8-K
SCHEDULE 13D/A May 18, 2026
4 May 18, 2026
4 May 18, 2026
4 May 18, 2026
4 May 18, 2026
4 May 18, 2026
SCHEDULE 13D/A May 14, 2026
4 May 14, 2026
8-K May 13, 2026 8-K
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
DEFA14A Apr 28, 2026 DEFA14A
ARS Apr 28, 2026 ARS
DEF 14A Apr 28, 2026 DEF 14A
← Newer Page 2 of 28 · 676 filings Older →